Anti-major histocompatibility complex antibody responses to simian B cells do not protect macaques against SIV(mac) infection

AIDS Research and Human Retroviruses

Volumn 13, Issue 11, 1997, Pages 923-931

  Polyanskaya, Natalya ^a   Sharpe, Sally ^a   Cook, Nicola ^a   Leech, Sharon ^a   Banks, Julia ^a   Dennis, Mike ^a   Hall, Graham ^a   Stott, Jim ^b   Cranage, Martin ^a  

^a PUBLIC HEALTH ENGLAND   (United Kingdom)

^b NATIONAL INSTITUTE FOR BIOLOGICAL STANDARDS AND CONTROL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY;

ALLOIMMUNIZATION; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY RESPONSE; ANTIBODY TITER; ARTICLE; B LYMPHOCYTE; CONTROLLED STUDY; IMMUNIZATION; IMMUNOPHENOTYPING; IMMUNOTHERAPY; MACACA; MAJOR HISTOCOMPATIBILITY COMPLEX; MIXED LYMPHOCYTE REACTION; NONHUMAN; PRIORITY JOURNAL; RETROVIRUS INFECTION; RHESUS MONKEY; SIMIAN IMMUNODEFICIENCY VIRUS; VIRUS CELL TRANSFORMATION;

EID: 0030831191     PISSN: 08892229     EISSN: None     Source Type: Journal    
DOI: 10.1089/aid.1997.13.923     Document Type: Article

References (34)

1. Desrosiers RC, Wyand MS, Kodama T, Ringler DJ, Arthur LO, Sehgal PK, Letvin NL, King NW, and Daniel MD: Vaccine protection against simian immunodeficiency virus infection. Proc Natl Acad Sci USA 1989;86:6353-6357.
2. Murphey-Corb M, Martin LN, Davison-Fairburn B, Montelaro RC, Miller M, West M, Ohkawa S, Baskin GB, Zhang J-Y, Putney SD, Allison AC, and Eppstein DA: A formalin-inactivated whole SIV vaccine confers protection in macaques. Science 1989;246:1293-1297.
3. Carlson JR, McGraw TP, Keddie E, Yee JL, Rosenthal A, Langlois AJ, Dickover R, Donovan R, Luciw PA, Jennings MB, and Gardner MB: Vaccine protection of rhesus macaques against simian immunodeficiency virus infection. AIDS Res Hum Retroviruses 1990; 6:1239-1241.
4. Stott EJ, Chan WL, Mills KHG, Page M, Taffs F, Cranage M, Greenaway P, and Kitchin P: Preliminary report: Protection of cynomolgus macaques against simian immunodeficiency virus by fixed infected-cell vaccine. Lancet 1990;336:1538-1541.
5. Stott EJ, Kitchin PA, Page M, Flanagan B, Taffs LF, Chan WL, Mills KHG, Silvera P and Rodgers A: Anti-cell antibody in macaques. Nature (London) 1991;353:393.
6. Cranage MP, Polyanskaya N, McBride B, Cook N, Ashworth LAE, Dennis M, Baskerville A, Greenaway PJ, Corcoran T, Kitchin P, Rose J, Murphey-Corb M, Desrosiers RC, Stott EJ, and Farrar GH: Studies on the specificity of the vaccine effect elicited by inactivated simian immunodeficiency virus. AIDS Res Hum Retroviruses 1993;9:13-22.
7. Putkonen P, Nilsson C, Hild K, Benthin R, Cranage M, Aubertin AM, and Biberfeld G: Whole inactivated SIV vaccine grown on human cells fails to protect against homologous SIV grown on simian cells. J Med Primatol 1993;21:108-112.
8. Hunsmann G, Dormont D, LeGrand R, Cranage M, Greenaway P, Stahl-Hennig C, Rossi G, Verani P, Stott J, Kitchin P, Osterhaus A, DeVries P, Kurth R, Norley S, Heeney J, Biberfeld G, and Putkonen P: Protection of macaques against simian immunodeficiency virus infection with inactivated vaccines: Comparison of adjuvants, doses and challenge viruses. Vaccine 1995;13:295-300.
9. Stott EJ, Almond N, Kent K, Chan WL, Cranage MP, Kitchin PA, Mills KHG, Page M, and Rud E: Animals models in the development of AIDS vaccine. Huitieme Colloque Des Cent Gardes 1993; 131-137.
10. Le Grand R, Vogt G, Vaslin B, Roques P, Theodoro F, Aubertin AM, and Dormont D: Specific and non-specific immunity and protection of macaques against SIV infection. Vaccine 1992;10:873-879.
11. Arthur LO, Bess JW, Sowder RC, Benveniste RE, Mann DL, Chermann JC, and Henderson LE: Cellular proteins bound to immunodeficiency viruses: Implications for pathogenesis and vaccines. Science 1992;258:1935-1938.
12. Chan WL, Rodgers A, Hancock DR, Taffs F, Kitchin P, Farrar G, and Liew FY: Protection in simian immunodeficiency virus-vaccinated monkeys correlates with anti-HLA class I antibody response. J Exp Med 1992;176:1203-1207.
13. Langlois AJ, Weinhold KJ, Matthews TJ, Greenberg ML, and Bolognesi DP: Detection of anti-human cell antibodies in sera from macaques immunised with whole inactivated virus. AIDS Res Hum Retroviruses 1992;8:1641-1652.
14. Bergmeier LA, Walker J, Tao L, Cranage M, and Lehner T: Antibodies to human and non-human primate cellular and culture medium components in macaques vaccinated with the simian immunodeficiency vinis. Immunology 1994;83:213-220.
15. Arthur LO, Bess JW, Urban RG, Strominger JL, Morton WR, Mann DL, Henderson LE, and Benveniste RE: Macaques immunized with HLA-DR are protected from challenge with simian immunodeficiency virus. J Virol 1995;69:3117-3124.
16. mac-32H- AIDS 1995;9:223-228.
17. Code of Practice for the Housing and Care of Animals Used in Scientific Procedures. Home Office Publication 107. HMSO, London, 1989.
18. Rabin H, Neubauer R, Hopkins R, Dzhikidze E, Shevtsova Z, and Lapin B: Transforming activity and antigenicity of an Epstein-Barr-like virus from lymphoblastoid cell lines of baboon with lymphoid disease. Intervirology 1977;8:240-249.
19. Urbaniak SJ, McCann MC, White AG, Barclay GR, and Kay AB: Tests of immune function. In: Handbook of Experimental Immunology, Vol. 4: Applications of Immunological Methods in Biomedical Sciences (Weir DM, ed.), 4th Ed., Blackwell Scientific Publications, Oxford, 1986, pp. 126.6-126.8.
20. Rud EW, Cranage M, Yon J, Quirk J, Ogilvie L, Cook N, Webster S, Dennis M, and Clarke BE: Molecular and biological characterization of simian immunodeficiency virus macaque strain 32H proviral clones containing nef size variants. J Gen Virol 1994; 75:529-543.
21. Kitchin PA, Almond N, Szotyroi Z, Fromholc CE, McAlpine L, Silvera P, Stott EJ, Cranage M, Baskerville A, and Schild G: The use of the polymerase chain reaction for the detection of simian immunodeficiency virus in experimental infected macaques. J Virol Methods 1990;28:85-100.
22. mac251 (32H isolate) in cynomolgus macaques for use as a challenge in vaccination studies. In: Animal Models in AIDS (Schellekens H and Horzinek MC, eds.). Elsevier Science Publishers B.V., Amsterdam, 1990, pp. 115-129.
23. Shearer GM and Clerici M: Alloimmunisation as an AIDS vaccine? Science 1993;262:161-162.
24. Kiprov DD, Sheppard HW, and Hanson CV: Alloimmunisation to prevent AIDS. Science 1994;263:737-738.
25. Haynes BF: Scientific and social issues of human immunodeficiency virus vaccine development. Science 1993;260:1279-1286.
26. Manning CH and Heise ER: Establishment and characterization of Macaca fascicularis lymphoblastoid cell lines. J Med Primatol 1992;21:15-23.
27. Merlu B, Néel D, Goussault Y, and Charron DJ: HLA class I and class II molecules expressed in monocytes, B cells and EBV transformed cells are differentially glycosylated. In: Immunobiology of HLA (Dupont B, ed.), Vol. 2. Springer-Verlag, New York, 1989, p. 364.
28. Giavedoni LD, Planelles V, Haigwood NL, Ahmad S, Kluge JD, Marthas ML, Gardner MB, Luciw PA, and Yilma TD: Immune responses of rhesus macaques to recombinant simian immunodeficiency virus gp130 does not protect from challenge infection. J Virol 1993;67:577-583.
29. Ahmad S, Lohman B, Marthas M, Giavedoni L, El-Amad Z, Haigwood NL, Scandella CJ, Gardner MB, Luciw PA, and Yilma T: Reduced virus load in rhesus macaques immunized with recombinant gp160 and challenged with simian immunodeficiency virus. AIDS Res Hum Retroviruses 1994;10:195-204.
30. + nef-specific cytotoxic T cells in vaccinated macaques. Nature Med 1995; 1:1167-1173.
31. Lehner T, Wang Y, Cranage M, Bergmeier LA, Mitchell E, Tao L, Hall G, Dennis M, Cook N, Brookes R, Klavinskis L, Jones I, Doyle C, and Ward R: Protective mucosal immunity elicited by targeted iliac lymph node immunization with a subunit SIV envelope and core vaccine in macaques. Nature Med 1996;2:767-775.
32. Brühl P, Kerschbaum A, Zimmermann K, Eibl MM, and Mannhalter JW: Allostimulated lymphocytes inhibit replication of HIV type 1. AIDS Res Hum Retroviruses 1996;12:31-37.
33. Robinson WE Jr, Gorny MK, Xu J-Y, Mitchell WM, and Zolla-Pazner S: Two immunodominant domains of gp41 bind antibodies which enhance human immunodeficiency virus type 1 infection in vitro. J Virol 1991;65:4169-4176.
34. Mitchell WM, Torres J, Johnson PR, Hirsch V, Yilma T, Gardner MB, and Robinson WR Jr: Antibodies to the putative SIV infection-enhancing domain diminish beneficial effects of an SIV gp160 vaccine in rhesus macaques. AIDS 1995;9:27-34.